Bingfeng Zuo

2.1k total citations
20 papers, 1.6k citations indexed

About

Bingfeng Zuo is a scholar working on Molecular Biology, Immunology and Biotechnology. According to data from OpenAlex, Bingfeng Zuo has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Biotechnology. Recurrent topics in Bingfeng Zuo's work include Extracellular vesicles in disease (7 papers), Immunotherapy and Immune Responses (6 papers) and RNA Interference and Gene Delivery (4 papers). Bingfeng Zuo is often cited by papers focused on Extracellular vesicles in disease (7 papers), Immunotherapy and Immune Responses (6 papers) and RNA Interference and Gene Delivery (4 papers). Bingfeng Zuo collaborates with scholars based in China, Singapore and United States. Bingfeng Zuo's co-authors include HaiFang Yin, Xianjun Gao, Zhen Lu, Quan Rao, Renwei Jing, Qi Han, Qibing Zhou, Yiqi Seow, Zhili Liu and A‐Bin You and has published in prestigious journals such as Nature Communications, PLoS ONE and Biomaterials.

In The Last Decade

Bingfeng Zuo

20 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingfeng Zuo China 15 1.4k 591 413 255 174 20 1.6k
Ji Min Oh South Korea 21 1.4k 1.1× 712 1.2× 399 1.0× 360 1.4× 255 1.5× 50 2.1k
François Mercier Canada 16 1.1k 0.8× 428 0.7× 533 1.3× 119 0.5× 311 1.8× 51 2.1k
Dihan Zhu China 14 1.0k 0.8× 786 1.3× 264 0.6× 53 0.2× 57 0.3× 20 1.4k
Michael Rosu‐Myles Canada 23 704 0.5× 242 0.4× 262 0.6× 66 0.3× 322 1.9× 48 1.4k
Stefanie Hiltbrunner Switzerland 17 819 0.6× 467 0.8× 390 0.9× 113 0.4× 284 1.6× 32 1.3k
Suzan Imren United States 20 769 0.6× 384 0.6× 172 0.4× 88 0.3× 420 2.4× 43 1.5k
Anne-Kathleen Rupp Germany 8 1.6k 1.1× 966 1.6× 350 0.8× 140 0.5× 155 0.9× 9 1.8k
Shin‐ichiro Ohno Japan 13 1.9k 1.4× 1.4k 2.3× 237 0.6× 211 0.8× 92 0.5× 32 2.2k
Stefano Ughetto United States 6 1.3k 1.0× 712 1.2× 184 0.4× 148 0.6× 47 0.3× 6 1.5k
A. Matsumoto Japan 13 1.5k 1.1× 818 1.4× 318 0.8× 291 1.1× 70 0.4× 20 1.6k

Countries citing papers authored by Bingfeng Zuo

Since Specialization
Citations

This map shows the geographic impact of Bingfeng Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingfeng Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingfeng Zuo more than expected).

Fields of papers citing papers by Bingfeng Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingfeng Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingfeng Zuo. The network helps show where Bingfeng Zuo may publish in the future.

Co-authorship network of co-authors of Bingfeng Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Bingfeng Zuo. A scholar is included among the top collaborators of Bingfeng Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingfeng Zuo. Bingfeng Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yang, et al.. (2023). Complete remission of tumors in mice with neoantigen-painted exosomes and anti-PD-1 therapy. Molecular Therapy. 31(12). 3579–3593. 23 indexed citations
2.
Jing, Renwei, Qian Wang, Lu Chen, et al.. (2022). Functional imaging and targeted drug delivery in mice and patient tumors with a cell nucleolus-localizing and tumor-targeting peptide. Biomaterials. 289. 121758–121758. 15 indexed citations
3.
Zuo, Bingfeng, Yang Zhang, Li Wu, et al.. (2022). Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses. Journal of Hematology & Oncology. 15(1). 46–46. 118 indexed citations
4.
Leng, Ling, Xue Dong, Xianjun Gao, et al.. (2020). Exosome-mediated improvement in membrane integrity and muscle function in dystrophic mice. Molecular Therapy. 29(4). 1459–1470. 24 indexed citations
5.
Zuo, Bingfeng, Qi Han, Zhen Lu, et al.. (2020). Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice. Nature Communications. 11(1). 1790–1790. 137 indexed citations
6.
Zhou, Xiaoli, Ruibin Li, Renwei Jing, Bingfeng Zuo, & Quan Zheng. (2020). Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively. Journal of Cancer Research and Clinical Oncology. 146(6). 1509–1521. 27 indexed citations
7.
Liu, Zhili, Zhen Lu, Renwei Jing, et al.. (2019). Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice. Theranostics. 9(14). 4006–4018. 8 indexed citations
8.
Jing, Renwei, Xiaoli Zhou, Yushuang Wei, et al.. (2018). Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 68(4). 1391–1411. 16 indexed citations
9.
Gao, Xianjun, Ning Ran, Xue Dong, et al.. (2018). Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy. Science Translational Medicine. 10(444). 326 indexed citations
10.
Shi, Yanan, et al.. (2017). 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) ameliorated dexamethasone induced hepatic gluconeogenesis through activation of Akt/FoxO1 pathway. Biochemical and Biophysical Research Communications. 493(1). 286–290. 5 indexed citations
11.
Lu, Zhen, Bingfeng Zuo, Renwei Jing, et al.. (2017). Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. Journal of Hepatology. 67(4). 739–748. 332 indexed citations
12.
You, A‐Bin, Manqing Cao, Bingfeng Zuo, et al.. (2016). Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models. Journal of Hematology & Oncology. 9(1). 20–20. 57 indexed citations
13.
Rao, Quan, A‐Bin You, Bingfeng Zuo, et al.. (2016). Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models. PLoS ONE. 11(1). e0148263–e0148263. 10 indexed citations
14.
Rao, Quan, Bingfeng Zuo, Zhen Lu, et al.. (2016). Tumor‐derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 64(2). 456–472. 235 indexed citations
15.
Li, Tingting, Sen Yin, Yuanzhan Wang, et al.. (2013). Infection of common marmosets with hepatitis C virus/GB virus-B chimeras. Hepatology. 59(3). 789–802. 29 indexed citations
16.
Zuo, Bingfeng, Jiao Yang, Fang Wang, et al.. (2012). Influences of lamin A levels on induction of pluripotent stem cells. Biology Open. 1(11). 1118–1127. 41 indexed citations
17.
Wang, Fang, Yu Yin, Xiaoying Ye, et al.. (2011). Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Research. 22(4). 757–768. 77 indexed citations
18.
Hu, Zhe, Lei Wang, Zhensheng Xie, et al.. (2011). Quantitative proteomics analysis of parthenogenetically induced pluripotent stem cells. Protein & Cell. 2(8). 631–646. 1 indexed citations
19.
Huang, Junjiu, Fang Wang, Maja Okuka, et al.. (2011). Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Research. 21(5). 779–792. 122 indexed citations
20.
Huang, Junjiu, Maja Okuka, Fang Wang, et al.. (2009). Generation of pluripotent stem cells from eggs of aging mice. Aging Cell. 9(2). 113–125. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji Min Oh Breakdown of academic impact, for papers by François Mercier Breakdown of academic impact, for papers by Dihan Zhu Breakdown of academic impact, for papers by Michael Rosu‐Myles Breakdown of academic impact, for papers by Stefanie Hiltbrunner Breakdown of academic impact, for papers by Suzan Imren Breakdown of academic impact, for papers by Anne-Kathleen Rupp Breakdown of academic impact, for papers by Shin‐ichiro Ohno Breakdown of academic impact, for papers by Stefano Ughetto Breakdown of academic impact, for papers by A. Matsumoto
Rankless by CCL
2026